Healthcare provider profile · identity verified

Robert Savillo, MD

Internal Medicine · NEW YORK, NY · NPI 1588751671

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	497	152
Amlodipine Besylate	Amlodipine Besylate	317	106
Rosuvastatin Calcium	Rosuvastatin Calcium	252	83
Metformin Hcl	Metformin Hcl	197	59
Losartan Potassium	Losartan Potassium	171	57
Levothyroxine Sodium	Levothyroxine Sodium	148	49
Metoprolol Succinate	Metoprolol Succinate	132	42
Zolpidem Tartrate	Zolpidem Tartrate	126	24
Omeprazole	Omeprazole	117	42
Albuterol Sulfate Hfa	Albuterol Sulfate	110	31
Jardiance	Empagliflozin	108	32
Alprazolam	Alprazolam	101	22
Ozempic	Semaglutide	101	24
Ezetimibe	Ezetimibe	93	28
Tamsulosin Hcl	Tamsulosin Hcl	89	29
Gabapentin	Gabapentin	87	22
Clonazepam	Clonazepam	82	18
Hydrochlorothiazide	Hydrochlorothiazide	81	27
Pantoprazole Sodium	Pantoprazole Sodium	75	26
Simvastatin	Simvastatin	74	23
Escitalopram Oxalate	Escitalopram Oxalate	72	25
Finasteride	Finasteride	66	17
Metformin Hcl Er	Metformin Hcl	60	21
Lisinopril	Lisinopril	58	18
Meclizine Hcl	Meclizine Hcl	57	14
Diclofenac Sodium	Diclofenac Sodium	54	19
Glimepiride	Glimepiride	54	17
Meloxicam	Meloxicam	54	14
Montelukast Sodium	Montelukast Sodium	54	16
Allopurinol	Allopurinol	52	17
Famotidine	Famotidine	50	18
Fluticasone Propionate	Fluticasone Propionate	46	17
Ibuprofen	Ibuprofen	46	13
Pioglitazone Hcl	Pioglitazone Hcl	46	14
Eliquis	Apixaban	45	14
Januvia	Sitagliptin Phosphate	45	13
Pregabalin	Pregabalin	45	suppressed
Lorazepam	Lorazepam	43	suppressed
Nifedipine Er	Nifedipine	43	suppressed
Sertraline Hcl	Sertraline Hcl	41	11
Trazodone Hcl	Trazodone Hcl	41	14
Alendronate Sodium	Alendronate Sodium	40	13
Clopidogrel	Clopidogrel Bisulfate	40	12
Olmesartan Medoxomil	Olmesartan Medoxomil	38	suppressed
Carvedilol	Carvedilol	37	19
Triamcinolone Acetonide	Triamcinolone Acetonide	37	19
Acetaminophen-Codeine	Acetaminophen With Codeine	36	suppressed
Tramadol Hcl	Tramadol Hcl	36	suppressed
Atenolol	Atenolol	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Valsartan	Valsartan	27	suppressed
Furosemide	Furosemide	26	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Tradjenta	Linagliptin	26	suppressed
Azithromycin	Azithromycin	24	22
Doxycycline Monohydrate	Doxycycline Monohydrate	24	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	17
Baclofen	Baclofen	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Prednisone	Prednisone	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Vascepa	Icosapent Ethyl	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Single Use Swab	Alcohol Antiseptic Pads	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Ammonium Lactate	Ammonium Lactate	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Codeine Sulfate	Codeine Sulfate	11	suppressed
Colchicine	Colchicine	11	suppressed
Desmopressin Acetate	Desmopressin (Nonrefrigerated)	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Humira Pen	Adalimumab	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Temazepam	Temazepam	11	suppressed
Torsemide	Torsemide	11	suppressed
Viberzi	Eluxadoline	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error